Ibrahim Yetunde, Haviland Miriam J, Hacker Michele R, Penzias Alan S, Thornton Kim L, Sakkas Denny
Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, 330 Brookline Ave. KS 3, Boston, MA, 02215, USA.
Utah Center for Reproductive Medicine, 675 Arapeen Drive, Suite 205, Salt Lake City, UT, 84108, USA.
J Assist Reprod Genet. 2017 Jun;34(6):759-764. doi: 10.1007/s10815-017-0920-8. Epub 2017 Apr 17.
The purpose of the study was to examine the association between serum progesterone levels on the day of hCG administration and birth weight among singleton live births after fresh embryo transfer.
This study was conducted as a retrospective cohort database analysis on patients who underwent IVF treatment cycles from January 2004 to April 2012. The study was performed at a University affiliated private infertility practice. All cycles that had achieved a singleton live birth after fresh embryo transfer and for which progesterone was measured on the day of hCG administration were examined. Generalized linear models were used to calculate mean birth weight and z-scores.
We analyzed 817 fresh IVF embryo transfers in which birth weight, gestational age, and progesterone (ng/mL) level on day of hCG administration were documented. While there was a decrease in birth weight as progesterone quartile [≤0.54; >0.54 to ≤0.81; >0.81 to ≤1.17; >1.17 ng/mL] increased, the difference in mean birth weights among the four quartiles was not statistically significant (p = 0.11) after adjusting for maternal age and peak estradiol levels. When dichotomizing based on a serum progesterone considered clinically elevated, cycles with progesterone >2.0 ng/mL had a significantly lower mean singleton birth weight (2860 g (95% CI 2642 g, 3079 g)) compared to cycles with progesterone ≤2.0 ng/mL (3167 g (95% CI 3122 g, 3211 g) p = 0.007)) after adjusting for maternal age and estradiol.
We demonstrated that caution should be exercised when performing fresh embryo transfers with elevated progesterone levels and in particular with levels (>2.0 ng/mL) as this may lead to lower birth weight.
本研究旨在探讨新鲜胚胎移植后单胎活产中,人绒毛膜促性腺激素(hCG)给药当天血清孕酮水平与出生体重之间的关联。
本研究是对2004年1月至2012年4月接受体外受精(IVF)治疗周期的患者进行的回顾性队列数据库分析。该研究在一所大学附属的私立不孕不育诊所进行。检查了所有在新鲜胚胎移植后实现单胎活产且在hCG给药当天测量了孕酮的周期。使用广义线性模型计算平均出生体重和z分数。
我们分析了817例新鲜IVF胚胎移植,记录了出生体重、孕周以及hCG给药当天的孕酮(ng/mL)水平。虽然随着孕酮四分位数[≤0.54;>0.54至≤0.81;>0.81至≤1.17;>1.17 ng/mL]升高出生体重有所下降,但在调整产妇年龄和雌二醇峰值水平后,四个四分位数之间的平均出生体重差异无统计学意义(p = 0.11)。当根据临床认为升高的血清孕酮进行二分法分析时,在调整产妇年龄和雌二醇后,孕酮>2.0 ng/mL的周期与孕酮≤2.0 ng/mL的周期相比,单胎平均出生体重显著更低(2860 g(95%可信区间2642 g,3079 g))(3167 g(95%可信区间3122 g,3211 g),p = 0.007)。
我们证明,在孕酮水平升高尤其是(>2.0 ng/mL)时进行新鲜胚胎移植应谨慎,因为这可能导致出生体重降低。